Olivier Bluteau

3.1k total citations
28 papers, 1.6k citations indexed

About

Olivier Bluteau is a scholar working on Molecular Biology, Surgery and Hematology. According to data from OpenAlex, Olivier Bluteau has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Surgery and 8 papers in Hematology. Recurrent topics in Olivier Bluteau's work include Acute Myeloid Leukemia Research (5 papers), Lipoproteins and Cardiovascular Health (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Olivier Bluteau is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Lipoproteins and Cardiovascular Health (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Olivier Bluteau collaborates with scholars based in France, United States and Belgium. Olivier Bluteau's co-authors include Jessica Zucman‐Rossi, Pierre Laurent‐Puig, Dominique Franco, Paulette Bioulac‐Sage, Jacques Belghiti, Patricia Legoix, Geneviève Monges, Charles Balabaud, Jean-Christophe Beaudoin and William Vainchenker and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Nature Genetics.

In The Last Decade

Olivier Bluteau

26 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivier Bluteau France 16 875 376 336 334 252 28 1.6k
Aurélie Hérault France 12 808 0.9× 337 0.9× 433 1.3× 259 0.8× 394 1.6× 15 1.7k
Sorina Radulescu United Kingdom 10 784 0.9× 512 1.4× 359 1.1× 447 1.3× 160 0.6× 10 1.5k
J.Y. Scoazec France 16 425 0.5× 450 1.2× 210 0.6× 214 0.6× 124 0.5× 35 1.2k
Thomas Jamieson United Kingdom 12 526 0.6× 611 1.6× 284 0.8× 275 0.8× 117 0.5× 25 1.5k
Kang–Da Liu China 18 600 0.7× 302 0.8× 411 1.2× 120 0.4× 329 1.3× 41 1.2k
Gaëlle Cubel France 10 350 0.4× 223 0.6× 720 2.1× 516 1.5× 218 0.9× 10 1.2k
S. Bretti Italy 13 449 0.5× 391 1.0× 552 1.6× 250 0.7× 104 0.4× 33 1.3k
Tatsushi Kato Japan 9 1.3k 1.5× 401 1.1× 180 0.5× 173 0.5× 238 0.9× 25 1.8k
Binaifer Balsara United States 20 924 1.1× 398 1.1× 73 0.2× 151 0.5× 331 1.3× 38 1.6k
Miki Ohta Japan 20 980 1.1× 839 2.2× 98 0.3× 395 1.2× 217 0.9× 35 1.9k

Countries citing papers authored by Olivier Bluteau

Since Specialization
Citations

This map shows the geographic impact of Olivier Bluteau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Bluteau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Bluteau more than expected).

Fields of papers citing papers by Olivier Bluteau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Bluteau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Bluteau. The network helps show where Olivier Bluteau may publish in the future.

Co-authorship network of co-authors of Olivier Bluteau

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Bluteau. A scholar is included among the top collaborators of Olivier Bluteau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Bluteau. Olivier Bluteau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Carreau, Valérie, Maryse Guérin, Éric Frisdal, et al.. (2023). Transcriptomic profile helps to identify high-risk heterozygous familial hypercholesterolemia patients. Archives of cardiovascular diseases. 117(1). S107–S108. 1 indexed citations
3.
Bluteau, Olivier, Bertrand Cariou, Valérie Carreau, et al.. (2023). Additive Effect of APOE Rare Variants on the Phenotype of Familial Hypercholesterolemia. Arteriosclerosis Thrombosis and Vascular Biology. 43(7). e270–e278. 3 indexed citations
4.
Bluteau, Olivier, Bertrand Cariou, Valérie Carreau, et al.. (2023). Additive effect of APOE rare variants on the phenotype of familial hypercholesterolemia. Atherosclerosis. 379. S26–S26.
5.
Cacemiro, Maira da Costa, Olivier Bluteau, Delphine Muller, et al.. (2018). Rare type 1-like and type 2-like calreticulin mutants induce similar myeloproliferative neoplasms as prevalent type 1 and 2 mutants in mice. Oncogene. 38(10). 1651–1660. 8 indexed citations
6.
Bluteau, Olivier, Kahia Messaoudi, Francesco Marangoni, et al.. (2016). The cell division control protein 42–Src family kinase–neural Wiskott–Aldrich syndrome protein pathway regulates human proplatelet formation. Journal of Thrombosis and Haemostasis. 14(12). 2524–2535. 17 indexed citations
7.
Hilpert, Morgane, Céline Legrand, Dominique Bluteau, et al.. (2014). p19INK4d Controls Hematopoietic Stem Cells in a Cell-Autonomous Manner during Genotoxic Stress and through the Microenvironment during Aging. Stem Cell Reports. 3(6). 1085–1102. 24 indexed citations
8.
Bluteau, Olivier, Kahia Messaoudi, Siham Boukour, et al.. (2013). Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanisms. Cell Death and Disease. 4(7). e738–e738. 28 indexed citations
9.
Bluteau, Olivier, Thierry Langlois, Paola Rivera-Muñoz, et al.. (2013). Developmental changes in human megakaryopoiesis. Journal of Thrombosis and Haemostasis. 11(9). 1730–1741. 48 indexed citations
10.
Gastou, Marc, Thierry Leblanc, Corinne Hurtaud, et al.. (2012). Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitro. Cell Death and Disease. 3(7). e356–e356. 58 indexed citations
11.
Lordier, Larissa, Dominique Bluteau, Abdelali Jalil, et al.. (2012). RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization. Nature Communications. 3(1). 717–717. 103 indexed citations
12.
D’Angelo, Anna, Olivier Bluteau, Miguel A. García-González, et al.. (2010). Hepatocyte nuclear factor 1α and β control terminal differentiation and cell fate commitment in the gut epithelium. Development. 137(9). 1573–1582. 79 indexed citations
13.
Evrard, Solène, Olivier Bluteau, M Tulliez, et al.. (2010). Thrombospondin-1 is not the major activator of TGF-β1 in thrombopoietin-induced myelofibrosis. Blood. 117(1). 246–249. 19 indexed citations
14.
Toledo, Franck, Olivier Bluteau, & Iva Simeonova. (2007). Réactivation de p53 dans les tumeurs : une stratégie antitumorale prometteuse. médecine/sciences. 23(6-7). 565–567. 3 indexed citations
15.
Cazals‐Hatem, Dominique, Sandra Rebouissou, Paulette Bioulac‐Sage, et al.. (2004). Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. Journal of Hepatology. 41(2). 292–298. 102 indexed citations
16.
Laurent‐Puig, Pierre, Olivier Bluteau, Franck Zinzindohoué, et al.. (2003). Frequent mutations of hepatocyte nuclear factor 1 in colorectal cancer with microsatellite instability. Gastroenterology. 124(5). 1311–1314. 17 indexed citations
17.
Bluteau, Olivier, Emmanuelle Jeannot, Paulette Bioulac‐Sage, et al.. (2002). Bi-allelic inactivation of TCF1 in hepatic adenomas. Nature Genetics. 32(2). 312–315. 241 indexed citations
18.
Bluteau, Olivier, Jean-Christophe Beaudoin, Patricia Pasturaud, et al.. (2002). Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping. Oncogene. 21(8). 1225–1232. 50 indexed citations
19.
Bluteau, Olivier, Pierre Laurent‐Puig, & Jessica Zucman‐Rossi. (2001). [Genetic alterations in hepatocellular carcinomas: associations with clinical parameters].. PubMed. 25(12). 1067–77. 1 indexed citations
20.
Legoix, Patricia, Olivier Bluteau, Jan Bayer, et al.. (1999). Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity. Oncogene. 18(27). 4044–4046. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aurélie Hérault Breakdown of academic impact, for papers by Sorina Radulescu Breakdown of academic impact, for papers by J.Y. Scoazec Breakdown of academic impact, for papers by Thomas Jamieson Breakdown of academic impact, for papers by Kang–Da Liu Breakdown of academic impact, for papers by Gaëlle Cubel Breakdown of academic impact, for papers by S. Bretti Breakdown of academic impact, for papers by Tatsushi Kato Breakdown of academic impact, for papers by Binaifer Balsara Breakdown of academic impact, for papers by Miki Ohta
Rankless by CCL
2026